Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

Growth hormone and adipose tissue: beyond the adipocyte

Berryman DE., List EO., Sackmann-Sala L., Lubbers E., Munn R., Kopchick JJ.

Narrative Review, published in Growth Horm IGF Res (2011) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Growth Horm IGF Res (2011)
Reported sample size
—
Source database
Europe PMC
PMID
21470887
PMCID
PMC3112270
DOI
10.1016/j.ghir.2011.03.002
Citations
58

Abstract (original English)

The last two decades have seen resurgence in research focused on adipose tissue. In part, the enhanced interest stems from an alarming increase in obesity rates worldwide. However, an understanding that this once simple tissue is significantly more intricate and interactive than previously realized has fostered additional attention. While few would argue that growth hormone (GH) radically alters fat mass, newer findings revealing the complexity of adipose tissue requires that GH's influence on this tissue be reexamined. Therefore, the objective of this review is to describe the more recent understanding of adipose tissue and to summarize our current knowledge of how GH may influence and contribute to these newer complexities of this tissue with special focus on the available data from mice with altered GH action.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueExtracellular MatrixAdipocytesAnimalsHumansMiceGrowth HormoneBody Composition

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.